Indonesia-MoH
15
2
3
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
27%
4 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Moringa Oleifera and Phoenix Dactylifera L. Effects on Cortisol and Breast Milk in Postpartum Depression
Role: collaborator
Intermittent Preventive Treatment With Dihydroartemisinin-piperaquine in Papua, Indonesia
Role: collaborator
INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old
Role: collaborator
UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects
Role: collaborator
UNAIR Inactivated COVID-19 Vaccine as Homologue Booster (Immunobridging Study)
Role: collaborator
UNAIR Inactivated COVID-19 Vaccine as Heterologue Booster (Immunobridging Study)
Role: collaborator
UNAIR Inactivated COVID-19 Vaccine
Role: collaborator
UNAIR Inactivated COVID-19 Vaccine Phase III (Immunobridging Study)
Role: collaborator
Dendritic Cell Vaccine to Prevent COVID-19
Role: lead
Endurance Exercise on nrf2 mRNA Expression Gene and VO2max
Role: collaborator
Protein Supplementation of Snakehead Fish Cookies on Pregnant Women
Role: collaborator
Natural Antioxidant Intake After Exercise Can Oxidative Stress in the Third Trimester of Pragnancy
Role: collaborator
Post Disaster Nutrition Intervention for Under-two-year-old Children in Lombok Indonesia
Role: collaborator
Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Indonesia
Role: collaborator
Study of ACTs Plus Primaquine for Uncomplicated Plasmodium Vivax Malaria
Role: collaborator
All 15 trials loaded